Search
Aurinia Pharmaceuticals Inc
AUPHAdd to Watchlist
16.460USD
+0.320+1.98%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.15BMarket Cap
7.38P/E TTM
Aurinia Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Aurinia Pharmaceuticals Inc is 6.86, ranking 287 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 7.38, which is 2924.19% below the recent high of 223.33 and 999.89% above the recent low of -66.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
